市場調查報告書
商品編碼
1327563
大腸癌篩檢檢驗的全球市場 - 市場規模(金額·數量·ASP):各市場區隔,佔有率,趨勢,SWOT分析,法規和償付的形勢,治療,預測(~2033年)Colorectal Cancer Screening Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
本報告提供全球大腸癌篩檢檢驗市場相關調查分析,提供各市場區隔的市場規模,市場趨勢,競爭情形,COVID-19影響等資訊。
市場模式的主要內容如下列。
已上市的大腸癌篩檢檢驗和不斷變化的競爭格局
世界,地區,國家層級的市場固有考察
通過獲取真正的大局(包括醫療保健系統的概述)來促進對市場的瞭解。此外,市場准入部分可讓您通過有關報銷政策和監管環境的信息更深入地瞭解市場動態。
對像企業
Colorectal Cancer Screening Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.
The model discusses in detail the impact of COVID-19 on Colorectal Cancer Screening Tests market for the year 2020 and beyond. Coverage and participation rates of CRC screening plans vary considerably depending on the country. In general, CRC screening is recommended for individuals aged 50-75 years of age.
Fecal occult blood tests are sometimes performed for diagnostic purposes in symptomatic patients with indications such as anaemia, iron-deficiency, abdominal pain, altered bowel habits, and suspected gastrointestinal bleeding.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Colorectal Cancer Screening Tests and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Eiken Chemical Co Ltd, Sentinel CH. SpA, Alfresa Pharma Corp, Showa Denko Materials Co Ltd, Danaher Corp, Hemosure Inc, Medline Industries Inc, QuidelOrtho Corp, Sekisui Diagnostics LLC, Epigenomics AG, Exact Sciences Corp, Aerscher Diagnostics LLC, Thermo Fisher Scientific Inc, Boditech Med Inc, McKesson Corp, Propper Manufacturing Co Inc, and others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:
The model will enable you to: